Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学TIL Therapy, Melanoma

Jason Chesney

MD, PhD

🏢University of Louisville🌐USA

Director, James Graham Brown Cancer Center

38
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Jason Chesney is a medical oncologist and principal investigator in the C-144-01 trial of lifileucel in patients with advanced melanoma who had progressed on immune checkpoint inhibitors. His center was one of the primary sites for the pivotal trial and he has contributed key data on response durability and safety. He champions the integration of TIL therapy into the melanoma treatment algorithm.

Share:

🧪Research Fields 研究领域

lifileucel C-144-01 melanoma
TIL after PD-1 failure melanoma
adoptive cell therapy combinations
melanoma immunotherapy
TIL durability of response

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Jason Chesney 的研究动态

Follow Jason Chesney's research updates

留下邮箱,当我们发布与 Jason Chesney(University of Louisville)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment